(3R)-piperidin-3-amine,dihydrochloride | CAS:334618-23-4

We serve (3R)-piperidin-3-amine,dihydrochloride CAS:334618-23-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(3R)-piperidin-3-amine,dihydrochloride

Chemical Name:(3R)-piperidin-3-amine,dihydrochloride
CAS.NO:334618-23-4
Synonyms:(R)-(-)-3-Piperidinamine dihydrochloride
(R)-3-Piperidinaminedihydrochloride
Molecular Formula:C5H14Cl2N2
Molecular Weight:173.08400
 
Physical and Chemical Properties:
Melting point:190-195ºC
Boiling point:241.9ºC
Flash point:100.1ºC
 
UN No.: UN1920
Hazard class: 3 categories 
Packing level: Class III
 
Specification:
Appearance:White powder
Purity:≥99.0%
Moisture:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Alogliptin
 
Note:The product under valid patents will not be offered to the countries covered by patents.



Contact us for information like (3R)-piperidin-3-amine,dihydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(R)-3-Piperidinaminedihydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(3R)-piperidin-3-amine,dihydrochloride Use and application,(3R)-piperidin-3-amine,dihydrochloride technical grade,usp/ep/jp grade.


Related News: The injection has previously proven to be as effective as standard daily pills with three active ingredients when administered monthly and also once every two months.5-Fluoro-2-methylaniline manufacturer Both Xinhua and the Global Times have published videos of drones warning various people in rural areas that masks need to be worn in “these times.” The drones were seen scolding an elderly lady and chasing a child down the road.nervonic acid supplier Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).(2R)-2-Deoxy-2-fluoro-2-methyl-D-erythropentonic acid gamma-lactone 3,5-dibenzoate vendor Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).When a new strain emerges that has not yet been identified, as is the case with the current outbreak in China, it temporarily becomes known as a novel coronavirus (nCoV).